These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1779726)

  • 21. Brain MRI with single-dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: comparison with 0.15 mmol/kg Gadoterate meglumine.
    Kramer H; Runge VM; Naul LG; Loynachan AT; Reiser MF; Wintersperger BJ
    AJR Am J Roentgenol; 2010 May; 194(5):1337-42. PubMed ID: 20410423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI contrast enhancement by Mn-TPPS in experimental rat brain tumor with peripheral benzodiazepine receptors.
    Ikezaki K; Nomura T; Takahashi M; Zieroth BF; Fukui M
    Acta Neurochir Suppl (Wien); 1994; 60():353-5. PubMed ID: 7976588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetically-labeled sensitized splenocytes to identify glioma by MRI: a preliminary study.
    Arbab AS; Rad AM; Iskander AS; Jafari-Khouzani K; Brown SL; Churchman JL; Ding G; Jiang Q; Frank JA; Soltanian-Zadeh H; Peck DJ
    Magn Reson Med; 2007 Sep; 58(3):519-26. PubMed ID: 17763342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
    Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
    J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I
    Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
    Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
    J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
    Ni Y; Petré C; Miao Y; Yu J; Cresens E; Adriaens P; Bosmans H; Semmler W; Baert AL; Marchal G
    Invest Radiol; 1997 Dec; 32(12):770-9. PubMed ID: 9406018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
    Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
    J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
    Runge VM; Lee C; Iten AL; Williams NM
    Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging of experimental rat brain tumors: histopathological evaluation.
    Baba T; Moriguchi M; Natori Y; Katsuki C; Inoue T; Fukui M
    Surg Neurol; 1990 Dec; 34(6):378-82. PubMed ID: 2244301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy.
    Huang LR; Straubinger RM; Kahl SB; Koo MS; Alletto JJ; Mazurchuk R; Chau RI; Thamer SL; Fiel RJ
    J Magn Reson Imaging; 1993; 3(2):351-6. PubMed ID: 8448397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gliomas: Motexafin Gadolinium-enhanced Molecular MR Imaging and Optical Imaging for Potential Intraoperative Delineation of Tumor Margins.
    Qiu L; Zhang F; Shi Y; Bai Z; Wang J; Li Y; Lee D; Ingraham C; Feng X; Yang X
    Radiology; 2016 May; 279(2):400-9. PubMed ID: 26599802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model.
    Adzamli K; Yablonskiy DA; Chicoine MR; Won EK; Galen KP; Zahner MC; Woolsey TA; Ackerman JJ
    Magn Reson Med; 2003 Mar; 49(3):586-90. PubMed ID: 12594765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and detection of experimental rat gliomas using magnetic resonance imaging.
    Vonarbourg A; Sapin A; Lemaire L; Franconi F; Menei P; Jallet P; Le Jeune JJ
    MAGMA; 2004 Dec; 17(3-6):133-9. PubMed ID: 15503254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H; Enmi J; Teramoto N; Hayashi T; Yamamoto A; Tsuji T; Naito H; Iida H
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on the 9L rat brain tumor model using MRI.
    Ross BD; Chenevert TL; Garwood M; Kim B; Stegman LD; Ben-Yoseph O; Zwolshen J; Rehemtulla A; Sunkara PS
    NMR Biomed; 2003 Apr; 16(2):67-76. PubMed ID: 12730947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic contrast-enhancing properties of manganese-mesoporphyrin and manganese-TPPS4. A comparative magnetic resonance imaging study in rats.
    Schmiedl UP; Nelson JA; Starr FL; Schmidt R
    Invest Radiol; 1992 Jul; 27(7):536-42. PubMed ID: 1644554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous manganese-mesoporphyrin as a magnetic resonance imaging contrast agent: an experimental model using VX-2 carcinoma in rabbits.
    Robinson DH; Schmiedl UP; Starr FL; Nelson JA; Malek R
    Acad Radiol; 1995 Jan; 2(1):43-9. PubMed ID: 9419523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular susceptibility weighted imaging of the glioma rim in a mouse model.
    Blasiak B; Landry J; Tyson R; Sharp J; Iqbal U; Abulrob A; Rushforth D; Matyas J; Ponjevic D; Sutherland GR; Wolfsberger S; Tomanek B
    J Neurosci Methods; 2014 Apr; 226():132-138. PubMed ID: 24525326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.